The EEF1A2 gene expression as risk predictor in localized prostate cancer

The EEF1A2 gene expression as risk predictor in localized prostate cancer

Abstract Background Besides clinical stage and Gleason score, risk-stratification of prostate cancer in the pretherapeutic setting mainly relies on the serum PSA level. Yet, this is associated with many uncertainties. With regard to therapy decision-making, additional markers are needed to allow an...

Full description

Bibliographic Details
Main Authors: Thomas Stefan Worst, Frank Waldbillig, Abdallah Abdelhadi, Cleo-Aron Weis, Maria Gottschalt, Annette Steidler, Jost von Hardenberg, Maurice Stephan Michel, Philipp Erben
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Urology
Subjects:
EEF1A2
Prostate cancer
Risk stratification
Biomarker
Expression
Outcome prediction
Online Access:http://link.springer.com/article/10.1186/s12894-017-0278-3

Internet

http://link.springer.com/article/10.1186/s12894-017-0278-3

Similar Items